| Estimated research and development investment needed to bring a new medicine to market, 2009-2018 OJ Wouters, M McKee, J Luyten Jama 323 (9), 844-853, 2020 | 1236 | 2020 |
| Assessing vaccine hesitancy in the UK population using a generalized vaccine hesitancy survey instrument J Luyten, L Bruyneel, AJ Van Hoek Vaccine 37 (18), 2494-2501, 2019 | 181 | 2019 |
| The social value of vaccination programs: beyond cost-effectiveness J Luyten, P Beutels Health Affairs 35 (2), 212-218, 2016 | 95 | 2016 |
| Willingness to get vaccinated against Covid-19 and attitudes toward vaccination in general R Kessels, J Luyten, S Tubeuf Vaccine 39 (33), 4716-4722, 2021 | 85 | 2021 |
| Public preferences for prioritizing preventive and curative health care interventions: a discrete choice experiment J Luyten, R Kessels, P Goos, P Beutels Value in Health 18 (2), 224-233, 2015 | 80 | 2015 |
| Costing infectious disease outbreaks for economic evaluation: a review for hepatitis A J Luyten, P Beutels Pharmacoeconomics 27, 379-389, 2009 | 65 | 2009 |
| Challenges and opportunities for occupational health and safety after the COVID-19 lockdowns L Godderis, J Luyten Occupational and environmental medicine 77 (8), 511-512, 2020 | 55 | 2020 |
| Economic evaluation of mental health interventions: an introduction to cost-utility analysis J Luyten, H Naci, M Knapp BMJ Ment Health 19 (2), 49-53, 2016 | 48 | 2016 |
| Rationing of a scarce life‐saving resource: Public preferences for prioritizing COVID‐19 vaccination J Luyten, S Tubeuf, R Kessels Health economics 31 (2), 342-362, 2022 | 42* | 2022 |
| Productivity estimation in economic evaluations of occupational health and safety interventions: a systematic review J Steel, L Godderis, J Luyten Scandinavian journal of work, environment & health 44 (5), 458-474, 2018 | 39 | 2018 |
| Economic evaluation of vaccines: Belgian reflections on the need for a broader perspective L Annemans, P Beutels, DE Bloom, W De Backer, O Ethgen, J Luyten, ... Value in Health 24 (1), 105-111, 2021 | 35 | 2021 |
| Quantifying the public's view on social value judgments in vaccine decision-making: a discrete choice experiment J Luyten, R Kessels, KE Atkins, M Jit, AJ Van Hoek Social Science & Medicine 228, 181-193, 2019 | 34 | 2019 |
| Kicking against the pricks: vaccine sceptics have a different social orientation J Luyten, P Desmet, V Dorgali, N Hens, P Beutels The European Journal of Public Health 24 (2), 310-314, 2014 | 33 | 2014 |
| Vaccination policy and ethical challenges posed by herd immunity, suboptimal uptake and subgroup targeting J Luyten, A Vandevelde, P Van Damme, P Beutels Public health ethics 4 (3), 280-291, 2011 | 33 | 2011 |
| The Sexual Ethics of HPV Vaccination for Boys J Luyten, B Engelen, P Beutels HEC Forum 26 (1), 1-16, 2013 | 27 | 2013 |
| Public preferences over efficiency, equity and autonomy in vaccination policy: an empirical study J Luyten, V Dorgali, N Hens, P Beutels Social Science & Medicine 77, 84-89, 2013 | 23 | 2013 |
| Imputing QALYs from Single Time Point Health State Descriptions on the EQ-5D and the SF-6D: A Comparison of Methods for Hepatitis A Patients J Luyten, C Marais, N Hens, K De Schrijver, P Beutels Value in Health, 2011 | 22 | 2011 |
| Ethical considerations for movement mapping to identify disease transmission hotspots BC de Jong, BM Gaye, J Luyten, B van Buitenen, E André, CJ Meehan, ... Emerging infectious diseases 25 (7), 2019 | 21 | 2019 |
| Cost-effectiveness of hepatitis A vaccination for adults in Belgium J Luyten, S Van de Sande, K De Schrijver, P Van Damme, P Beutels Vaccine 30 (42), 6070-6080, 2012 | 21 | 2012 |
| Belgium's response to the COVID-19 pandemic J Luyten, E Schokkaert Health Economics, Policy and Law 17 (1), 37-47, 2022 | 19 | 2022 |
Philippe BeutelsProfessor at Vaccine & Infectious Disease Institute, University of Antwerp, Belgium在 uantwerpen.be 的电子邮件经过验证
